ArticleFrontiers in oncology2022

CAR-T therapy followed by allogeneic hematopoietic stem cell transplantation for refractory/relapsed acute B lymphocytic leukemia: Long-term follow-up results.

Zhihui Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.